Swiss National Bank
SLRN

Swiss National Bank’s ACELYRIN SLRN Stock Holding History

Swiss National Bank’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,300
Closed -$286K – 2526
2023
Q4 		$286K Sell
38,300
-25,800
-40% -$220K ﹤0.01% 2525
2023
Q3 		$652K Buy
+64,100
New +$1.36M ﹤0.01% 2440

Other funds holding SLRN

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Swiss National Bank's SLRN Position: Q1 2024 in Review

Swiss National Bank sold out of ACELYRIN (SLRN) in Q1 2024, closing a stake of 38,300 shares — an estimated $286K sold.

Swiss National Bank first reported a position in SLRN in Q3 2023 and held it in 2 quarters. The position peaked at $652K in Q3 2023. 109 funds tracked by Wall St. Rank hold SLRN as of Q1 2024.

  • Swiss National Bank reported no remaining ACELYRIN position as of Q1 2024 after selling out during the quarter.
  • Swiss National Bank sold 38,300 ACELYRIN shares in Q1 2024, an estimated $286K.
  • Swiss National Bank first reported a position in ACELYRIN in Q3 2023 and held it in 2 quarters.
  • Swiss National Bank's ACELYRIN position peaked at $652K in Q3 2023.
  • 109 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2024.

Based on Swiss National Bank's 13F filing for Q1 2024, filed 7 May 2024.